Terms: = Testicular cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
33 results:
1. clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.
Blok JM; van der Poel HG; Kerst JM; Bex A; Brouwer OR; Bosch JLHR; Horenblas S; Meijer RP
World J Urol; 2021 Jun; 39(6):1969-1976. PubMed ID: 32955662
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review.
Haarsma R; Blok JM; van Putten K; Meijer RP
Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Characterization of testicular Germ Cell Tumors Relapsing After Chemotherapy.
Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
[TBL] [Abstract] [Full Text] [Related]
5. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
[TBL] [Abstract] [Full Text] [Related]
6. Gonadal function in adult male patients with congenital adrenal hyperplasia.
Engels M; Gehrmann K; Falhammar H; Webb EA; Nordenström A; Sweep FC; Span PN; van Herwaarden AE; Rohayem J; Richter-Unruh A; Bouvattier C; Köhler B; Kortmann BB; Arlt W; Roeleveld N; Reisch N; Stikkelbroeck NMML; Claahsen-van der Grinten HL;
Eur J Endocrinol; 2018 Mar; 178(3):285-294. PubMed ID: 29339528
[TBL] [Abstract] [Full Text] [Related]
7. [clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
8. Evaluation of the decision-making process in the conservative approach to small testicular masses.
Benelli A; Varca V; Derchi L; Gregori A; Carmignani G; Simonato A
Urologia; 2017 Apr; 84(2):83-87. PubMed ID: 28315499
[TBL] [Abstract] [Full Text] [Related]
9. Plasma Cytokines Correlated With Disease Characteristics, Progression-Free Survival, and Overall Survival in testicular Germ-Cell Tumor Patients.
Svetlovska D; Miskovska V; Cholujova D; Gronesova P; Cingelova S; Chovanec M; Sycova-Mila Z; Obertova J; Palacka P; Rajec J; Kalavska K; Usakova V; Luha J; Ondrus D; Spanik S; Mardiak J; Mego M
Clin Genitourin Cancer; 2017 Jun; 15(3):411-416.e2. PubMed ID: 28237180
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
[TBL] [Abstract] [Full Text] [Related]
11. Pelvic Lymph Node Dissection in Patients Treated for Testis cancer: The Memorial Sloan Kettering cancer Center Experience.
Alanee SR; Carver BS; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2016 Sep; 95():128-31. PubMed ID: 27235751
[TBL] [Abstract] [Full Text] [Related]
12. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome, Hormonal Status, Gonadotrope Axis, and testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.
Bouvattier C; Esterle L; Renoult-Pierre P; de la Perrière AB; Illouz F; Kerlan V; Pascal-Vigneron V; Drui D; Christin-Maitre S; Galland F; Brue T; Reznik Y; Schillo F; Pinsard D; Piguel X; Chabrier G; Decoudier B; Emy P; Tauveron I; Raffin-Sanson ML; Bertherat J; Kuhn JM; Caron P; Cartigny M; Chabre O; Dewailly D; Morel Y; Touraine P; Tardy-Guidollet V; Young J
J Clin Endocrinol Metab; 2015 Jun; 100(6):2303-13. PubMed ID: 25822101
[TBL] [Abstract] [Full Text] [Related]
14. clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract] [Full Text] [Related]
15. Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer.
Sapre N; Pedersen J; Hong MK; Harewood L; Peters J; Costello AJ; Hovens CM; Corcoran NM
BJU Int; 2012 Dec; 110 Suppl 4():58-63. PubMed ID: 23194127
[TBL] [Abstract] [Full Text] [Related]
16. Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.
Huber J; Herpel E; Jakobi H; Hadaschik BA; Pahernik S; Hohenfellner M
Urol Oncol; 2013 Oct; 31(7):990-6. PubMed ID: 22386623
[TBL] [Abstract] [Full Text] [Related]
17. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases.
Contreras AL; Punar M; Tamboli P; Tu SM; Pisters L; Moran C; Czerniak BA; Guo CC
Hum Pathol; 2010 Jun; 41(6):832-7. PubMed ID: 20153508
[TBL] [Abstract] [Full Text] [Related]
18. Long-term clinical outcome in patients with stage-I nonseminomatous germ cell cancer. A critical review of own treatment modalities in a retrospective study.
Seseke S; Bierwirth S; Strauss A; Ringert RH; Seseke F
Int Braz J Urol; 2008; 34(6):715-22; discussion 723-4. PubMed ID: 19111076
[TBL] [Abstract] [Full Text] [Related]
19. clinical outcome and predictors of survival in late relapse of germ cell tumor.
Sharp DS; Carver BS; Eggener SE; Kondagunta GV; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2008 Dec; 26(34):5524-9. PubMed ID: 18936477
[TBL] [Abstract] [Full Text] [Related]
20. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract] [Full Text] [Related]
[Next]